Stroke Trial, Recruiting NCT06709950 Sponsor: Chonbuk National University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06709950
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 40 and 75 years old who have had a stroke.
  • People who have had their first-ever stroke (either a blocked blood vessel or a bleeding stroke), confirmed by a brain scan such as a CT or MRI.
  • People who are between 2 weeks and 3 months past the date their stroke occurred.
  • People whose stroke has left them with mild to moderate effects, meaning some difficulty with daily activities but some ability to move around independently (a score of 2 or 3 on a scale called the Modified Rankin Scale — confirm with trial site if unsure where this falls).
  • People who have enough thinking and understanding ability to follow study instructions and take part in art therapy sessions.
  • People who have mild to moderate levels of depression, anxiety, or stress at the start of the study.
  • People who can understand and express themselves well enough in language to interact with a therapist during sessions.
  • People who have enough physical ability to take part in art activities, such as being able to make basic movements with their arms or hands.
  • People who live close enough to the treatment location to attend sessions regularly and have a stable home situation.
  • People whose family members are also willing to be informed about the study and sign a consent form agreeing to participate.
  • People who have not received any psychological therapy, art therapy, or similar rehabilitation program in the past 6 months.

Who may not be able to join:

  • People who have been diagnosed with a serious mental health condition such as schizophrenia or bipolar disorder, or who currently have severe depression, anxiety, or stress.
  • People who have serious physical health conditions such as advanced cancer, heart failure, acute coronary syndrome, severe kidney failure, or severe chronic breathing problems.
  • People with serious sensory difficulties — such as blindness, profound hearing loss, or other sensory impairments that cannot be corrected — that would prevent full participation in art activities.
  • People with severe difficulties speaking or understanding language (such as severe aphasia) that would make it hard to communicate during therapy.
  • People who currently have a dependence on or history of misusing alcohol or other substances.
  • People who have severe allergic reactions to materials that may be used in art therapy, such as paint, clay, or musical instruments, or who have experienced physical discomfort from similar materials before.
  • People, or whose family members, are unwilling to participate or are unable to sign a written consent form.
  • People who have other circumstances — such as a major recent life event like bereavement or divorce — that researchers believe could affect their participation or the study results (confirm with trial site for specific situations).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 17621611192

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chonbuk National University
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
1 March 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Fugl-Meyer Assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov